Brownsville Drops to Level 1 On Threat Level Matrix

Vaccination is the best protection against the virus

Translate to Spanish or other 102 languages!

Effective 10-31-2022, the City of Brownsville has decreased the threat level matrix to level one due to a decline in COVID-19 cases.Iage for illustration purposes.
Effective 10-31-2022, the City of Brownsville has decreased the threat level matrix to level one due to a decline in COVID-19 cases.Iage for illustration purposes.

Mega Doctor News

- Advertisement -

BROWNSVILLE, Texas – Effective 10-31-2022, the City of Brownsville has decreased the threat level matrix to level one due to a decline in COVID-19 cases. During the last few months, virus transmission rates have been steadily lowering, the city encourages citizens to resume normal contact with others unless sick.

The number of positive COVID-19 cases has decreased to less than 50 cases. Currently, the vaccination rate for Cameron County is 94.64% for individuals 65 years and older and 83.8% for people six months and older.  

“Let’s continue having low numbers by remembering to continue practicing safety measures such as remembering to wash their hands, use hand sanitizer, practice social distancing, and wear a mask. Citizens are also advised to get their vaccine or booster if they have not done so already, it is the safest and best line of defense against a virus such as COVID,” said Dr. Arturo Rodriguez, Public Health Director. 

- Advertisement -

Free vaccination clinics are offered by the city. To find a location near you visit btxcares.com or vaccines.gov.  Call the COVID-19 Hotline at 956-394-0012 or visit the Brownsville Cares website for more information regarding COVID-19 vaccines.

For more information or to schedule media interviews, please contact the Communications and Marketing Department at communications@brownsvilletx.gov or (956) 547-6505.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Moderna and Merck Report Positive Phase 3 Results for Personalized Cancer Therapy

Moderna and Merck have reached a major clinical milestone after their investigational individualized cancer therapy, combined with Merck’s Keytruda, produced positive results in a Phase 3 study involving patients with high-risk melanoma.

STHS Scores Fourth Consecutive 5-Star Rating for Diabetic Care

Diabetes remains one of the nation’s most pressing health challenges, with a disease once largely associated with older adults now affecting younger populations at an alarming rate.

STHS to Examine Back Pain in New “South Texas Healthy Living” Episode, Aug, 30th

Back pain is the most common pain condition reported by Americans, affecting nearly 65 million U.S. adults annually, with an estimated 16 million living with chronic symptoms, according to the Centers for Disease Control and Prevention (CDC).

Physicians Urge Updating Child Vaccinations Before School Starts

Texas physicians have an important message for parents as the new school year is about to begin: Ensure your children are current on all their necessary vaccinations. 
- Advertisement -